Navigation Links
Asthma & Allergy Foundation CEO Appointed to NIH Council
Date:1/9/2009

BETHESDA, Md., Jan. 10 /PRNewswire-USNewswire/ -- The Asthma and Allergy Foundation of America (AAFA) announces that its President and CEO, William M. McLin, has been appointed to the Council of the National Institute of Allergy and Infectious Disease (NIAID), an institute of the National Institutes of Health (NIH), for a four-year term. The Council is a chartered advisory committee that provides a diverse perspective on science, health and the human impact of diseases.

The Council serves as NIAID's main advisory body on key functions, including: performing peer review, advising on policy, reviewing programs, and developing and clearing concepts for program announcements, requests for applications and requests for proposals. NIAID often seeks the Council's advice before changing policies for training, health information dissemination, administration, budget and other areas.

McLin has been head of AAFA since 2001 at a time when asthma and allergic diseases in the U.S. have experienced alarming growth; prevalence has nearly doubled over the past 25 years. McLin helped the 55-year-old not-for-profit patient group transition into the 21st Century to better educate patients and caregivers, as well as advocate and conduct research for the asthma and allergy community.

McLin will serve on the advisory subcommittee of the Division of Allergy, Immunology, and Transplantation through October 31, 2012. During program reviews, the subcommittee advises on a program's effectiveness in meeting Institute goals and the needs of the allergy and immunology community.

Before coming to AAFA, McLin served as Director of Government Relations and Executive Vice President during his 20-year tenure with the Epilepsy Foundation of America. He also provided interim executive oversight services to numerous nonprofit organizations. Mr. McLin has held key positions with the National Health Council, the American Society of Association Executives, the President's Committee for Employment of People with Disabilities and the Public Advisory Roundtable of the American Thoracic Society.

NIAID conducts and supports basic and applied research to better understand, treat and prevent infectious, immunologic and allergic diseases. For more than 50 years, NIAID research has led to new therapies, vaccines, diagnostic tests and other technologies that have improved the health of millions of people around the world. Visit www.niaid.nih.gov.

AAFA is the leading national not-for-profit patient advocacy organization for people with asthma and allergies. It is dedicated to improving the quality of life for people with asthma and allergies through education, advocacy and research. For more information, visit www.aafa.org.


'/>"/>
SOURCE The Asthma and Allergy Foundation of America
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Nitric Oxide Monitoring of Little Benefit for Kids Asthma
2. NO help: Nitric oxide monitoring does not help most children with asthma
3. American Asthma Foundation Announces Breakthrough Discovery
4. Antifungal Drug May Help Ease Asthma
5. Fungal pill could provide asthma relief for 150,000 UK sufferers
6. Anti-fungal drug offers great benefits to some with severe asthma
7. Mayo Clinic study finds increased risk of pneumococcal disease in asthma patients
8. School Program Helps Cut Asthma Risks
9. Antacid Medication in Pregnancy May Increase Childhood Asthma
10. Next Safety Develops an Air-Based Asthma Medication Inhaler That Does Not Use a Refrigerant Propellant
11. GlaxoSmithKline Statement on FDA Advisory Committee Vote on Use of Asthma Medicines Containing Long-Acting Beta-Agonists
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... ... fertility once they have been diagnosed with endometriosis. These women need a treatment ... also require a comprehensive approach that can help for preservation of fertility and ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room ... Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of ...
(Date:6/24/2016)... ... , ... A recent article published June 14 on E Online ... on to state that individuals are now more comfortable seeking to undergo not only ... calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) ...
(Date:6/24/2016)... ... ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys are ... for this recognition are considered among the top 2 percent of lawyers practicing within ... of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. Bloom, ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented ... in Emergency Medicine conference in Ponte Vedra Beach, FL. The awards honor the ... Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , “With this award, ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Research ... Devices Global Market - Forecast to 2022" report to ... the treatment method for the patients with kidney failure, it ... excess fluid from the patient,s blood and thus the treatment ... potassium and chloride in balance. Increasing number ...
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... -- Bracket , a leading clinical trial technology and ... platform, Bracket eCOA (SM) 6.0, at the 52 nd ... 2016 in Philadelphia , Pennsylvania.  A demonstration ... of its kind to fully integrate with RTSM, will be ... is a flexible platform for electronic clinical outcomes assessments that ...
Breaking Medicine Technology: